GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TFDP1 | hg19_v2_chr13_+_114238997_114239077 | 0.64 | 6.3e-27 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_27022839 Show fit | 87.07 |
ENST00000457599.2
|
AT rich interactive domain 1A (SWI-like) |
|
chr6_-_86352982 Show fit | 79.95 |
ENST00000369622.3
|
synaptotagmin binding, cytoplasmic RNA interacting protein |
|
chr17_-_73179046 Show fit | 59.63 |
ENST00000314523.7
ENST00000420826.2 |
small ubiquitin-like modifier 2 |
|
chr11_+_85955787 Show fit | 53.05 |
ENST00000528180.1
|
embryonic ectoderm development |
|
chr17_-_73178599 Show fit | 50.79 |
ENST00000578238.1
|
small ubiquitin-like modifier 2 |
|
chrX_-_16887963 Show fit | 47.90 |
ENST00000380084.4
|
retinoblastoma binding protein 7 |
|
chr1_+_43148625 Show fit | 47.83 |
ENST00000436427.1
|
Y box binding protein 1 |
|
chr17_+_34900737 Show fit | 47.45 |
ENST00000304718.4
ENST00000485685.2 |
gametogenetin binding protein 2 |
|
chrX_+_64887512 Show fit | 44.74 |
ENST00000360270.5
|
moesin |
|
chr1_+_62902308 Show fit | 43.59 |
ENST00000339950.4
|
ubiquitin specific peptidase 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
32.5 | 227.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
2.1 | 176.9 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
3.5 | 164.0 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
18.9 | 132.0 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
23.2 | 116.0 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
2.9 | 94.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
2.1 | 85.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
2.6 | 85.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
8.4 | 84.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
16.1 | 80.6 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 289.0 | GO:0016605 | PML body(GO:0016605) |
24.3 | 194.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.4 | 156.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
6.4 | 154.5 | GO:0071564 | npBAF complex(GO:0071564) |
0.5 | 154.2 | GO:0000785 | chromatin(GO:0000785) |
0.7 | 103.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
4.7 | 99.0 | GO:0000812 | Swr1 complex(GO:0000812) |
0.4 | 93.8 | GO:0072562 | blood microparticle(GO:0072562) |
5.2 | 93.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.4 | 93.5 | GO:0031965 | nuclear membrane(GO:0031965) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 183.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.7 | 147.0 | GO:0051015 | actin filament binding(GO:0051015) |
11.2 | 145.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
3.2 | 139.7 | GO:0004407 | histone deacetylase activity(GO:0004407) |
4.6 | 139.1 | GO:0008143 | poly(A) binding(GO:0008143) |
4.2 | 129.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
3.2 | 129.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
3.6 | 127.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
9.8 | 117.7 | GO:0031386 | protein tag(GO:0031386) |
2.6 | 114.7 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 222.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.9 | 188.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
3.3 | 138.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.3 | 132.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.4 | 114.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
1.7 | 94.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.2 | 91.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
1.7 | 87.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
2.4 | 82.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
2.6 | 76.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 356.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
3.7 | 162.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
2.4 | 152.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.4 | 148.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
1.4 | 143.9 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
6.4 | 127.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.4 | 103.9 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
2.6 | 82.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
4.0 | 68.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.5 | 68.6 | REACTOME TRANSLATION | Genes involved in Translation |